Combining Erlotinib and Cetuximab is Associated with Activity in Patients with Non Small Cell Lung Cancer (including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutat...

Por Wheler, Jennifer J., Tsimberidou, Apostolia M., Falchook, Gerald S., Zinner, Ralph G., Hong, David S., Fok, Jansina Y., Fu, Siqing, Piha-Paul, Sarina A., Naing, Aung, Kurzrock, Razelle
Publicado em 2013

Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase...

Por Wheler, Jennifer, Falchook, Gerald, Tsimberidou, Apostolia M., Hong, David, Naing, Aung, Piha-Paul, Sarina, Chen, Su S., Heymach, John, Fu, Siqing, Stephen, Bettzy, Fok, Jansina Y., Janku, Filip, Kurzrock, Razelle
Publicado em 2013

Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma

Por Hwang, Jee Young, Mangala, Lingegowda S., Fok, Jansina Y., Lin, Yvonne G., Merritt, William M., Spannuth, Whitney A., Nick, Alpa M., Fiterman, Derek J., Vivas-Mejia, Pablo E., Deavers, Michael T., Coleman, Robert L., Lopez-Berestein, Gabriel, Mehta, Kapil, Sood, Anil K.
Publicado em 2008